Concept:
The clinical presentation of recurrent skin eruptions, bone pain, elevated inflammatory markers, and the pathognomonic "bull's head" sign on a bone scan points directly to SAPHO syndrome.
SAPHO stands for Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis.
Explanation:
• SAPHO syndrome is an auto-inflammatory condition bridging rheumatology and dermatology. It is characterized by prominent osteitis and hyperostosis, most commonly affecting the anterior chest wall (sternoclavicular joints).
• The "bull's head" sign is seen on bone scintigraphy (Technetium-99m scan) due to intense radiotracer uptake in the manubriosternal and bilateral sternoclavicular joints, which visually resembles the head and horns of a bull.
• First-line, initial symptomatic therapy for the musculoskeletal pain and inflammation in SAPHO syndrome is Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). They provide significant relief in the majority of patients and are the recommended starting point.
• Option (B) and Option (C): If NSAIDs fail, second-line therapies include systemic corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs like MTX), Bisphosphonates (to target osteitis and bone remodeling), and Biologics (TNF-alpha inhibitors). These are not first-line.
• Option (D): While Cutibacterium acnes (formerly Propionibacterium acnes) has been cultured from bone biopsy samples in some SAPHO patients and long-term antibiotics (e.g., azithromycin or doxycycline) are sometimes used, NSAIDs remain the universally accepted initial step to control acute symptoms.
Final answer:
NSAIDs are the recognized initial first-line pharmacological treatment to manage the osteoarticular pain in SAPHO syndrome.